Last update :
28/04/2024
InfoStab
Infostab
List of drugs
List of drugs
Summary lists
Summary lists
Search for compatibilities
Search for compatibilities
Y-site compatibility table
Y-site compatibility table
References
References
Research teams
Research teams
Valistab
Valistab
Poster
Poster
Links
Links
Sponsors
Sponsors
Authors
Authors
User’s guide
User’s guide
Newsletter
Newsletter
References   References 3369  
Type : Manufacturer
Research teams :
Authors :
Title : Levofolinate de sodium Medac - Résumé des caractéristiques du produits
Reference : MEDAC France 2011
Level of Evidence : 
Manufacturer's stability data
Physical stability : 
Chemical stability : 
Other methods : 
Comments : 
List of drugs
InjectionFluorouracil Anticancer drug
Compatible 10,8 mg/ml + InjectionLevofolinate calcium 1,8 mg/ml + NaCl 0,9% or Glucose 5%
InjectionIrinotecan Anticancer drug
Compatible 0,2 mg/ml + InjectionLevofolinate calcium 0,2 mg/ml + NaCl 0,9% or Glucose 5%
Compatible 1,5 mg/ml + InjectionLevofolinate calcium 1,5 mg/ml + NaCl 0,9% or Glucose 5%
InjectionLevofolinate calcium Cytoprotective
Compatible 1,8 mg/ml + InjectionFluorouracil 10,8 mg/ml + NaCl 0,9% or Glucose 5%
Compatible 0,2 mg/ml + InjectionIrinotecan 0,2 mg/ml + NaCl 0,9% or Glucose 5%
Compatible 1,5 mg/ml + InjectionIrinotecan 1,5 mg/ml + NaCl 0,9% or Glucose 5%
Compatible 1,8 mg/ml + InjectionOxaliplatin 1,53 mg/ml + Glucose 5%
InjectionLevofolinate disodium Cytoprotective
Stability in solutions Glass NaCl 0,9% or Glucose 5% 1,8 mg/ml 20-25°C Light
72 Hour
Stability in solutions Glass NaCl 0,9% or Glucose 5% 3,6 mg/ml 20-25°C Light
72 Hour
InjectionOxaliplatin Anticancer drug
Compatible 1,53 mg/ml + InjectionLevofolinate calcium 1,8 mg/ml + Glucose 5%
  Mentions Légales